La Chapelle Heulin, France

Fabrice Pagniez

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: The University of Nantes. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Fabrice Pagniez. Retrieved from https://idiyas.com/inventor/fabrice-pagniez

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Fabrice Pagniez

Introduction

Fabrice Pagniez is an accomplished inventor based in La Chapelle Heulin, France. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds with therapeutic applications.

Latest Patents

Fabrice holds a patent for "Fused pyrimidinone and triazinone derivatives containing bridged nitrogen, their process of preparation and their therapeutic uses as antifungal and/or antiparasitic agents." This invention focuses on the creation of new fused pyrimidinone and triazinone derivatives that exhibit antifungal and antiparasitic properties. The patent highlights the innovative processes involved in the preparation of these compounds.

Career Highlights

Fabrice Pagniez is affiliated with the Université de Nantes, where he engages in research and development activities. His work has led to advancements in the understanding and application of chemical compounds in treating various infections.

Collaborations

Fabrice has collaborated with notable colleagues, including Cédric Loge and Rémi Guillon. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their field.

Conclusion

Fabrice Pagniez is a notable inventor whose work in developing antifungal and antiparasitic agents has the potential to impact the medical field significantly. His contributions through patents and collaborations reflect his commitment to advancing medicinal chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…